VPRIV (Shire US Manufacturing Inc.)
Welcome to the PulseAid listing for the VPRIV drug offered from Shire US Manufacturing Inc.. This Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Shire US Manufacturing Inc. |
| NON-PROPRIETARY NAME: | velaglucerase alfa |
| SUBSTANCE NAME: | VELAGLUCERASE ALFA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-02-26 |
| END MARKETING DATE: | 0000-00-00 |
VPRIV HUMAN PRESCRIPTION DRUG Details:
| Item Description | VPRIV from Shire US Manufacturing Inc. |
| LABELER NAME: | Shire US Manufacturing Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/mL) |
| START MARKETING DATE: | 2010-02-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54092-701_b799bee3-8e08-4f30-bc44-ce9202c98bed |
| PRODUCT NDC: | 54092-701 |
| APPLICATION NUMBER: | NDA022575 |
Other VELAGLUCERASE ALFA Pharmaceutical Manufacturers / Labelers:
